En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer

ArticleAçık Erişim

Özet

Objective: To assess the authors' experiences in en bloc pelvic resection with concomitant rectosigmoid colectomy and primary anastomosis as a part of primary cytoreductive surgery for patients with advanced ovarian cancer. Materials and Methods: A total of 22 patients with FIGO Stage IIB-IV epithelial ovarian cancer who underwent en bloc pelvic resection with anastomosis were retrospectively reviewed. Data analyses were carried out using SPSS 10.0 and descriptive statistics, Kaplan-Meier survival curves, and Log Rank (Mantel-Cox) test were used for statistical estimations. Results: Median age was 58.8 years. FIGO stage distribution of the patients was; one (4.5%) IIB, three (13.7%) IIC, three (13.7%) IIIA, six (27.3%) IIIB, and nine (40.9%) IIIC. Median peritoneal cancer index (PCI) was 8 (range 5-22) and optimal cytoreduction was achieved in 18 patients (81.8%) of whom 13 (59.1%) had no macroscopic residual disease (complete cytoreduction). There was no perioperative mortality. A total of nine complications occurred in seven (31.8%) patients. Anastomotic leakage was observed in one (4.5%) patient. There was no re-laparotomy. Mean follow-up time was 60 months. There were 15 (68.2%) recurrences of which 12 (80%) presented in extra-pelvic localizations. Mean disease-free survival (DFS) and overall survival (OVS) were estimated as 43.6 and 50.5 months, respectively. Patients with complete cytoreduction had a better DFS (p = 0.006) and OVS (p = 0.003) than those with incomplete cytoreduction. Conclusion: En bloc pelvic resection, as a part of surgical cytoreduction, seems to be a safe and effective procedure in many patients with advanced ovarian cancer if required. Despite relatively high general complication rate, anastomosis-related morbidity of this procedure is low as 0.8%. Nevertheless, surgical plan and perioperative care should be personalized according to medical and surgical conditions of the patient.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15746Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.12892/ejgo24792014Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYildirim, Y.
dc.contributor.authorErtas, I.E.
dc.contributor.authorNayki, U.
dc.contributor.authorUlug, P.
dc.contributor.authorNayki, C.
dc.contributor.authorYilmaz, I.
dc.contributor.authorGultekin, E.
dc.contributor.authorDogan, A.
dc.contributor.authorAykas, A.
dc.contributor.authorUlug, S.
dc.contributor.authorOzdemir, A.
dc.contributor.authorSolmaz, U.
dc.date.accessioned2026-10-18T20:30:35.617871855Z
dc.date.available2026-10-18T20:30:35.617871855Z
dc.date.issued2014
dc.description.abstractObjective: To assess the authors' experiences in en bloc pelvic resection with concomitant rectosigmoid colectomy and primary anastomosis as a part of primary cytoreductive surgery for patients with advanced ovarian cancer. Materials and Methods: A total of 22 patients with FIGO Stage IIB-IV epithelial ovarian cancer who underwent en bloc pelvic resection with anastomosis were retrospectively reviewed. Data analyses were carried out using SPSS 10.0 and descriptive statistics, Kaplan-Meier survival curves, and Log Rank (Mantel-Cox) test were used for statistical estimations. Results: Median age was 58.8 years. FIGO stage distribution of the patients was; one (4.5%) IIB, three (13.7%) IIC, three (13.7%) IIIA, six (27.3%) IIIB, and nine (40.9%) IIIC. Median peritoneal cancer index (PCI) was 8 (range 5-22) and optimal cytoreduction was achieved in 18 patients (81.8%) of whom 13 (59.1%) had no macroscopic residual disease (complete cytoreduction). There was no perioperative mortality. A total of nine complications occurred in seven (31.8%) patients. Anastomotic leakage was observed in one (4.5%) patient. There was no re-laparotomy. Mean follow-up time was 60 months. There were 15 (68.2%) recurrences of which 12 (80%) presented in extra-pelvic localizations. Mean disease-free survival (DFS) and overall survival (OVS) were estimated as 43.6 and 50.5 months, respectively. Patients with complete cytoreduction had a better DFS (p = 0.006) and OVS (p = 0.003) than those with incomplete cytoreduction. Conclusion: En bloc pelvic resection, as a part of surgical cytoreduction, seems to be a safe and effective procedure in many patients with advanced ovarian cancer if required. Despite relatively high general complication rate, anastomosis-related morbidity of this procedure is low as 0.8%. Nevertheless, surgical plan and perioperative care should be personalized according to medical and surgical conditions of the patient.
dc.identifier.doi10.12892/ejgo24792014
dc.identifier.endpage407
dc.identifier.issn0392-2936
dc.identifier.issue4
dc.identifier.pmid25118481
dc.identifier.scopus2-s2.0-84905110271
dc.identifier.startpage400
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15746
dc.identifier.volume35
dc.identifier.wosWOS:000339785000009
dc.language.isoen
dc.publisherS.O.G. CANADA Inc.
dc.relation.ispartofEuropean Journal of Gynaecological Oncology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCytoreductive surgery
dc.subjectEn-bloc pelvic resection
dc.subjectOvarian cancer
dc.subjectPrimary anastomosis
dc.subjectRectosigmoid colectomy
dc.subjectAdenocarcinoma
dc.subjectAdenocarcinoma, Clear Cell
dc.subjectAdenocarcinoma, Mucinous
dc.subjectAdult
dc.subjectAged
dc.subjectAnastomosis, Surgical
dc.subjectCarcinoma, Endometrioid
dc.subjectCohort Studies
dc.subjectColectomy
dc.subjectColon, Sigmoid
dc.subjectDisease-Free Survival
dc.subjectFemale
dc.subjectHumans
dc.subjectHysterectomy
dc.subjectKaplan-Meier Estimate
dc.subjectLymph Node Excision
dc.subjectMiddle Aged
dc.subjectNeoplasms, Glandular and Epithelial
dc.subjectOvarian Neoplasms
dc.subjectOvariectomy
dc.subjectPelvic Exenteration
dc.subjectPeritoneum
dc.subjectProctocolectomy, Restorative
dc.subjectRectum
dc.subjectRetrospective Studies
dc.titleEn-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus14
rdl.citation.wos11
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)